# Dexcom

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/dexcom/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company that develops, manufactures and distributes continuous glucose monitoring systems |
| OpenAlex ID | https://openalex.org/F4320316051 |
| ROR ID | https://ror.org/03ra42c27 |
| Works | 1,325 |

## Funder papers

- [Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes](https://scholariq.org/papers/oral-semaglutide-and-heart-failure-outcomes-in-persons-with-type-2-diabetes/)
- [Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial](https://scholariq.org/papers/impact-of-oral-semaglutide-on-kidney-outcomes-in-people-with-type-2-diabetes/)
- [Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry](https://scholariq.org/papers/population-level-risk-factors-for-kidney-outcomes-in-iga-nephropathy-the-cure/)
- [Population risk predictors of major adverse kidney events attributed to focal segmental glomerulosclerosis from the CURE-CKD registry](https://scholariq.org/papers/population-risk-predictors-of-major-adverse-kidney-events-attributed-to-focal/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.